Vibration clinical trials

Explore recruiting vibration clinical trials.

Recruiting vibration studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vibration trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease

Germany, Greece, Bulgaria, France, Denmark, Czechia +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults with Compensated Cirrhosis Secondary to Metabolic Dysfunction-Associated Steatohepatitis

Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Semaglutide 2.4mg for low responders after bariatric surgery

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Fazirsiran in Participants With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

Austria, Germany, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.- The CARAMEL Study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Effects of Metformin on hepatic venous pressure gradient in patients with cirrhosis and portal hypertension – A randomized placebo-controlled study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Vibration trials by city

Vibration in Toronto Vibration in Vancouver Vibration in Montreal Vibration in Calgary Vibration in Edmonton Vibration in Ottawa Vibration in Winnipeg Vibration in Quebec City Vibration in Hamilton Vibration in Kitchener Vibration in London Vibration in Halifax Vibration in New York Vibration in Los Angeles Vibration in Chicago Vibration in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease